1 Min Read
June 13 (Reuters) - Proteomics International Laboratories Ltd
* Clinical validation study confirms promarkerd can predict diabetic kidney disease better than any current measure Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.